Sort   by:  
 Page size 
MetabolomicsUntargeted metabolomic analysis in cats with naturally occurring inflammatory bowel disease and alimentary small cell lymphoma
Feline chronic enteropathy (CE) is a common gastrointestinal disorder in cats and mainly comprises inflammatory bowel disease (IBD) and small cell lymphoma (SCL). Differentiation between IBD and SCL can be diagnostically challenging. We characterized the fecal metabolome of 14 healthy cats and 22 ca...
2021-07-13 | MTBLS440 | MetaboLights
UnknownGiardia's Epithelial Cell Interaction In Vitro: Mimicking Asymptomatic Infection?
Not available
S-EPMC5622925 | biostudies-literature
MetabolomicsFatal COVID-19 pulmonary disease involves ferroptosis.

SARS-CoV-2 infection causes severe pulmonary manifestations, with poorly understood mechanisms and limited treatment options. Hyperferritinemia and disrupted lung iron homeostasis in COVID-19 patients imply that ferroptosis, an iron-dependent cell death, may occur. Immunostaining and lipidomic an...

2024-07-11 | MTBLS3107 | MetaboLights
UnknownManagement of high-risk acute pulmonary embolism: an emulated target trial analysis.
Not available
S-EPMC12018524 | biostudies-literature
UnknownA genome-wide association study of depressive symptoms.
Not available
S-EPMC3845085 | biostudies-literature
UnknownSafety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Single-Arm Trial.
Not available
S-EPMC9926325 | biostudies-literature
UnknownPrioritizing Measures That Matter Within a Person-Centered Oncology Learning Health System.
Not available
S-EPMC9219163 | biostudies-literature
UnknownGenome-wide meta-analyses identify multiple loci associated with smoking behavior.
Not available
S-EPMC2914600 | biostudies-literature
UnknownDistinct loci in the CHRNA5/CHRNA3/CHRNB4 gene cluster are associated with onset of regular smoking.
Not available
S-EPMC3947535 | biostudies-literature
UnknownIntegrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI.
Not available
S-EPMC11416444 | biostudies-literature
Sort   by:  
 Page size